News

The First Breathing For Diabetes App to Improve the Quality of Life for 537 Million People

New York, New York--(Newsfile Corp. - January 17, 2024) - The Breathing App has launched the first app that allows…

2 years ago

Luxury Addiction Rehab Expands Services Amid Rebranding

Private addiction and dual diagnosis treatment center Annandale Behavioral Health develops a comprehensive continuum of care for drug and alcohol…

2 years ago

AMC Health Announces Dr. Zebadiah Kimmel, MD, MBA, as Chief Product Officer

Dr. Kimmel brings more than 15 years of leadership to AMC HealthNEW YORK, NY / ACCESSWIRE / January 17, 2024…

2 years ago

CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)

HOUSTON, TX / ACCESSWIRE / January 17, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company…

2 years ago

NurExone and Inteligex Kick Off Chronic Spinal Cord Injury Research for Multi-Billion Dollar Healthcare Market

TORONTO and HAIFA, Israel, Jan. 17, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company”…

2 years ago

Elicio Therapeutics to Present ELI-002 7P (AMPLIFY-7P) Trial in Progress Poster on Phase 1/2 Study of Lymph Node-Targeted Vaccine at ASCO GI Symposium

AMPLIFY-7P study builds on preliminary positive findings from the 2-peptide formulation of ELI-002 published in Nature Medicine demonstrating tumor biomarker…

2 years ago

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors

Cleared First Four Monotherapy Doses and Initial Combination Cohort with No Dose Limiting Toxicities at any Dose Level KVA12123 Monotherapy…

2 years ago

INVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directors

INVO (NASDAQ: INVO) and NAYA Biosciences expect to close their previously announced merger in the first quarter of 2024Experienced, entrepreneurial leadership…

2 years ago

Daré Bioscience Announces Grant to Support Biotherapeutic Product Development

Grant funds support activities that will aid the ultimate development of bacteria-based biotherapeutic products designed to benefit women and newbornsSAN…

2 years ago